July 15: India’s pharmaceutical sector is witnessing a strong rise in innovation activity, with India-origin pharma patents registering significant growth and the industry’s research pipeline expanding to more than 1,095 projects, according to a recent report.
The increase in patent filings reflects the growing focus of Indian pharmaceutical companies on research and development, new drug discovery, and advanced healthcare solutions. The sector is increasingly moving towards innovation-led growth, strengthening its role in the global pharmaceutical landscape.
The report indicates that companies are investing in emerging areas such as biotechnology, complex medicines, specialty treatments, and next-generation healthcare technologies. This expanding innovation pipeline is expected to support the development of new therapies and improve access to advanced healthcare solutions.
Industry stakeholders believe the growth in intellectual property creation highlights India’s strengthening research ecosystem, supported by increased investments, scientific talent, and collaborations between pharmaceutical companies and research institutions.
India has long been recognised as a major global pharmaceutical hub, and the rise in patent activity further reinforces its evolving role from a manufacturing base to an innovation-driven healthcare partner.
With continued investment in research, technology, and scientific infrastructure, the Indian pharmaceutical industry is expected to play a larger role in shaping the future of global healthcare innovation.
